NCT06221761 is a NA clinical trial of not using antibiotic in Burn Infection, sponsored by Ruijin Hospital.

Who is sponsoring NCT06221761?

NCT06221761 is sponsored by Ruijin Hospital.

What drugs are being tested in NCT06221761?

Interventions in NCT06221761: not using antibiotic, using antibiotic.

What condition does NCT06221761 study?

NCT06221761 studies Burn Infection.

Is NCT06221761 still recruiting?

NCT06221761 is currently status unknown. Last updated 24 January 2024.

Last reviewed 2024-01-24 · How we verify

NCT06221761

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study on the Prophylactic Use of Antibiotics Within 72 Hours After Acute Burn Injury in Patients

Status unknown NA Last updated 24 January 2024

What this trial tests

NA trial testing not using antibiotic in Burn Infection in 240 participants. Status unknown.

Timeline

1 March 2024

Primary endpoint
1 March 2025

30 June 2025

Quick facts

Lead sponsor	Ruijin Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	240
Start date	1 March 2024
Primary completion	1 March 2025
Estimated completion	30 June 2025

Drugs / interventions tested

not using antibiotic — full drug profile →
using antibiotic — full drug profile →

Conditions studied

Burn Infection — all drugs for Burn Infection →

Sponsor

Ruijin Hospital

Who can join

18 and older, any sex, with Burn Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare in acute burn patients. The main question it aims to answer are: • what is the impact of early prophylactic use of antibiotics on prognosis Participants will be randomly divided into an antibiotic group and a non antibiotic group. Researchers will compare the two groups to see the 72 hour wound bacterial culture negative rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ruijin Hospital trials

Trials by the same sponsor.

NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06221761 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
Last refreshed: 24 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06221761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing